In conclusion, these data demonstrated that the activation of LAPTM5 in lung metastases is a common molecular event shared by several types of human cancer, and that the LAPTM5/WWP2-based lysosomal regulatory pathway mediates the ubiquitination and degradation of BMPR1A. This evidence concerns the gene LAPTM5 and cancer.